ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04060	Cytokine-cytokine receptor interaction	14/59	191/7206	2.45311477657e-10
ko04650	Natural killer cell mediated cytotoxicity	10/59	97/7206	4.44508967713e-09
ko05330	Allograft rejection	6/59	24/7206	2.7886599464e-08
ko04658	Th1 and Th2 cell differentiation	9/59	96/7206	6.56222376915e-08
ko04659	Th17 cell differentiation	9/59	106/7206	1.56049170237e-07
ko05310	Asthma	5/59	17/7206	1.77716927316e-07
ko05152	Tuberculosis	11/59	187/7206	2.53171519305e-07
ko05416	Viral myocarditis	7/59	55/7206	2.55792440071e-07
ko05150	Staphylococcus aureus infection	6/59	36/7206	3.74050192063e-07
ko05145	Toxoplasmosis	9/59	126/7206	6.89691150387e-07
ko05144	Malaria	6/59	45/7206	1.4775899626e-06
ko05140	Leishmaniasis	7/59	75/7206	2.20363854561e-06
ko05320	Autoimmune thyroid disease	5/59	29/7206	3.16371271084e-06
ko05321	Inflammatory bowel disease (IBD)	6/59	56/7206	5.49419647799e-06
ko04514	Cell adhesion molecules (CAMs)	8/59	130/7206	9.25881516981e-06
ko05332	Graft-versus-host disease	4/59	18/7206	1.138737525e-05
ko04640	Hematopoietic cell lineage	6/59	64/7206	1.20610261334e-05
ko04664	Fc epsilon RI signaling pathway	6/59	77/7206	3.51315369909e-05
ko05323	Rheumatoid arthritis	6/59	89/7206	7.98169927355e-05
ko04630	Jak-STAT signaling pathway	7/59	132/7206	9.1111127583e-05
ko05340	Primary immunodeficiency	4/59	30/7206	9.47731980374e-05
ko04940	Type I diabetes mellitus	4/59	32/7206	0.0001228494737
ko05322	Systemic lupus erythematosus	7/59	151/7206	0.000211330652962
ko04672	Intestinal immune network for IgA production	4/59	37/7206	0.000218849452884
ko05162	Measles	6/59	120/7206	0.000412502744147
ko04610	Complement and coagulation cascades	5/59	79/7206	0.000439323533079
ko04662	B cell receptor signaling pathway	5/59	88/7206	0.000721994483067
ko04064	NF-kappa B signaling pathway	5/59	96/7206	0.00107174151569
ko04145	Phagosome	6/59	162/7206	0.00198083246995
ko05166	HTLV-I infection	8/59	292/7206	0.00242088666024
ko04660	T cell receptor signaling pathway	5/59	124/7206	0.00331697917823
ko04612	Antigen processing and presentation	4/59	77/7206	0.00351637061457
ko05168	Herpes simplex infection	6/59	182/7206	0.00354813265017
ko04380	Osteoclast differentiation	5/59	134/7206	0.00462256806756
ko05133	Pertussis	4/59	87/7206	0.00544412193779
ko05169	Epstein-Barr virus infection	6/59	206/7206	0.006478333959
ko04620	Toll-like receptor signaling pathway	4/59	100/7206	0.00886637763908
ko04611	Platelet activation	5/59	163/7206	0.0104277646231
ko05164	Influenza A	5/59	167/7206	0.0115013367524
ko04666	Fc gamma R-mediated phagocytosis	4/59	122/7206	0.017397043117
ko05167	Kaposi's sarcoma-associated herpesvirus infection	5/59	191/7206	0.0195588648186
ko05142	Chagas disease (American trypanosomiasis)	4/59	130/7206	0.0214436458582
ko04062	Chemokine signaling pathway	5/59	201/7206	0.023799467813
ko05020	Prion diseases	2/59	40/7206	0.0421394206619
ko05146	Amoebiasis	3/59	99/7206	0.047036253915